ES2090167T3 - Uso topico de glicosaminoglicanos en la prevencion y el tratamiento de enfermedades que afectan al tracto vaginal cervical. - Google Patents

Uso topico de glicosaminoglicanos en la prevencion y el tratamiento de enfermedades que afectan al tracto vaginal cervical.

Info

Publication number
ES2090167T3
ES2090167T3 ES91106227T ES91106227T ES2090167T3 ES 2090167 T3 ES2090167 T3 ES 2090167T3 ES 91106227 T ES91106227 T ES 91106227T ES 91106227 T ES91106227 T ES 91106227T ES 2090167 T3 ES2090167 T3 ES 2090167T3
Authority
ES
Spain
Prior art keywords
prevention
treatment
glycosaminoglycans
diseases affecting
vaginal tract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91106227T
Other languages
English (en)
Inventor
Massimo Baldacci
Roberto Comi
Giovanna Comi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratori Baldacci SpA
Original Assignee
Laboratori Baldacci SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratori Baldacci SpA filed Critical Laboratori Baldacci SpA
Application granted granted Critical
Publication of ES2090167T3 publication Critical patent/ES2090167T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE DESCRIBE EL TRATAMIENTO TOPICO CON GLICOSAMINOGLICANOS, TANTO SOLOS COMO EN UNA MEZCLA, QUE ES UTIL EN LA PREVENCION Y EL TRATAMIENTO TERAPEUTICO DE PATOLOGIAS VAGINALES CERVICALES EN CONDICIONES DE CLIMATERIO Y POSCLIMATERIO, DE PATOLOGIAS VAGINALES INDUCIDAS POR AGENTES LESIVOS O DROGAS Y PATOLOGIAS VAGINALES INESPECIFICAS.
ES91106227T 1991-04-18 1991-04-18 Uso topico de glicosaminoglicanos en la prevencion y el tratamiento de enfermedades que afectan al tracto vaginal cervical. Expired - Lifetime ES2090167T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP19910106227 EP0509120B1 (en) 1991-04-18 1991-04-18 Topical use of glycosaminoglycans in the prevention and treatment of diseases affecting the cervical vaginal tract

Publications (1)

Publication Number Publication Date
ES2090167T3 true ES2090167T3 (es) 1996-10-16

Family

ID=8206638

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91106227T Expired - Lifetime ES2090167T3 (es) 1991-04-18 1991-04-18 Uso topico de glicosaminoglicanos en la prevencion y el tratamiento de enfermedades que afectan al tracto vaginal cervical.

Country Status (4)

Country Link
EP (1) EP0509120B1 (es)
DE (1) DE69120933T2 (es)
DK (1) DK0509120T3 (es)
ES (1) ES2090167T3 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629287A (en) * 1991-01-18 1997-05-13 University College London Depot formulations
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
EP0900804A2 (en) * 1993-03-01 1999-03-10 Glycan Pharmaceuticals, Inc. Analogs for specific oligosaccharide-protein interactions and uses therefor
AU8136801A (en) * 2000-07-31 2002-02-13 Dermal Res Lab Inc Methods of preventing or treating diseases and conditions using complex carbohydrates
US7879824B2 (en) 2001-07-31 2011-02-01 Dermal Research Laboratories, Inc. Methods of preventing or treating diseases and conditions using complex carbohydrates
ITBO20010361A1 (it) * 2001-06-07 2002-12-07 Farma Derma S R L Uso di acido ialuronico per la produzione di un preparato ad uso vaginale, in particolare per la cura degli stati atrofici e distrofici cerv
US8455458B2 (en) 2002-10-16 2013-06-04 Arthrodynamic Technologies, Animal Health Division, Inc. Composition and method for treating connective tissue damage
US9186375B2 (en) 2007-06-21 2015-11-17 Arthrodynamic Technologies, Animal Health Division, Inc. Glycosaminoglycan compositions in combination with stem cells
DE102010015350A1 (de) 2010-04-16 2011-10-20 Michael Zimmermann Vaginalapplikator
EP3442501A1 (en) 2016-04-15 2019-02-20 Fairhaven Health, LLC Compositions and methods for maintaining or enhancing homeostasis or function of female lower reproductive tract

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486416A (en) * 1981-03-02 1984-12-04 Soll David B Protection of human and animal cells subject to exposure to trauma
US4711780A (en) * 1984-06-11 1987-12-08 Fahim Mostafa S Composition and process for promoting epithelial regeneration
DE3441835A1 (de) * 1984-11-15 1986-05-22 Luitpold-Werk Chemisch-pharmazeutische Fabrik GmbH & Co, 8000 München Blutstillungsmittel
DK505488D0 (da) * 1987-12-21 1988-09-09 Bar Shalom Daniel Middel og anvendelse af samme

Also Published As

Publication number Publication date
EP0509120A1 (en) 1992-10-21
DE69120933T2 (de) 1997-01-16
DE69120933D1 (de) 1996-08-22
DK0509120T3 (da) 1996-08-12
EP0509120B1 (en) 1996-07-17

Similar Documents

Publication Publication Date Title
MY120802A (en) Absorbent article.
ES2170223T3 (es) Composicion farmaceutica que contiene hidratos de carbonato de lantano seleccionados.
EP0727210A3 (en) Analgesic agent and its use
TR199701490A2 (xx) 3-Hidroksipiridin-2-karbonasitamidester ve bunlar�n imalat�.
IL115733A (en) Binding agents to cd23 and their use in the manufacture of a medicament
PT777482E (pt) Composicao de combinacao para utilizacao em doencas imunologicas
ES2140565T3 (es) Nuevos derivados de pirazina-carboxamida, su preparacion y su utilizacion en medicamentos.
ES2090167T3 (es) Uso topico de glicosaminoglicanos en la prevencion y el tratamiento de enfermedades que afectan al tracto vaginal cervical.
KR920016088A (ko) 하부 요로 질환의 치료
CA2163118A1 (en) Aurintricaboxylic Acid Fractions and Analogues with Anti-Angiogenic Activity and Methods of Use
AU2749288A (en) Use of polysulfated heparins
ITMI992107A0 (it) Uso del baclofen nel trattamento dell'astinenza da etanolo
DK1621207T3 (da) Mixture of defibrotide and G-CSF, and its use for activating haematopoietic progenitors
ES2098316T3 (es) Procedimiento de purificacion de carrageninas comerciales.
AU2139388A (en) Glycosaminoglycane for the treatment of diabetic microangiopathy
FI945412L (fi) Alkoholit kaliumkanavan avaajina ja virtsanpidätyskyvyttömyyden hoidossa
PT721467E (pt) Utilizacao de relaxina como analgesico e paliativo para dor refractaria
ES2181915T3 (es) Ctla-8 en combinacionpn con g-csf y il-6, y uso de ctla-8 para tratar infecciones.
PT740657E (pt) 4-aril-isoindois com actividade analgesica
NZ334660A (en) use of sulodexide to treat diabetic retinopathy
KR960003718A (ko) 말초신경병 및 중추신경변성병의 치료에 유용한 의약의 제조를 위한 이펜프로딜 및 그 부분입체이성질체의 이용
AU551108B2 (en) Analgesic potentiation of zomepirac with butorphanol
UA26939C2 (uk) Засіб для лікуваhhя аутоімуhhих захворюваhь і спосіб їх лікуваhhя
NO901076L (no) Substituerte bifenyler.
SE8802040D0 (sv) New use

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 509120

Country of ref document: ES

FG2A Definitive protection

Ref document number: 509120

Country of ref document: ES